Some studies argued that anti-CTLA-4 antibodies produces anti-tumor effect by killing Tregs through antibody-dependent cell-mediated cytotoxicity because Fc domain is essential for ipilimumab anti-tumor function (117, 118). The gene discussed is CTLA4; the disease is neoplasm.